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 Abstract 
The objective of this review article is to study how technology is transferred in pharmaceutical industry. This 
review article is to discuss the procedure for technology transfer process in pharmaceutical industry, importance of 
technology transfer, reasons for using technology transfer, methods of technology transfer, facets of technology transfer, list 
of institutes in Indian assisting in technology transfer, organization of technology transfer, function of technology transfer, 
steps involved in technology transfer, few case of  involved in the technology transfer in the pharmaceutical industry and 
understand the aspects related with technology transfer. 
Keywords: Technology transfer, Technology transfer dossier, Exhibit batch, Process development laboratory. 
1. Introduction  
In the pharmaceutical industry, “Technology 
Transfer” means the processes of successful progress from 
drug discovery to product development, clinical trials and 
ultimately full-scale commercialization. 
There are 3 standards in the definition of technology:  
 First, knowledge must be systematic. This means that it 
must be organized in terms of providing solutions to 
problems.  
 Second, knowledge must exist in certain places like in 
someone’s head or in documents, and must be able to be 
presented, so no matter what it means it must be able to 
be transferred from one person to another.  
 Third, it must have purpose-orientation, so that it can be 
utilized for useful purposes in industry, farming, and 
commercial fields. 
Technology transfer, also called transfer of 
technology (TOT), is the process of transferring skills, 
knowledge, technologies, methods of manufacturing, 
samples of manufacturing and facilities among industries, 
governments or universities to ensure that scientific and 
technological developments are accessible to a wider range 
of users who can then further develop and exploit the 
technology into new products, processes, applications, 
materials or services. 
According to WHO, transfer of technology is 
defined as “a logical procedure that controls the transfer of 
any process together with its documentation and 
professional expertise between development and 
manufacture or between manufacture sites.” It is a 
systematic procedure that is followed in order to pass the 
documented knowledge and experience gained during 
development and or commercialization to an appropriate, 
responsible and authorized party. Technology transfer 
embodies both the transfer of documentation and the 
demonstrated ability of the receiving unit to effectively 
perform the critical elements of the transferred technology, 
to the satisfaction of all parties and any applicable 
regulatory bodies. 
There are 2 types of technology transfer vertical 
and horizontal. The vertical technology transfer means to 
transfer of the technology from basic research to the 
development & production respectively. The horizontal 
technology transfer means the movement and application of 
used in one place or the context to another place. It is the 
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process by which an original innovator of the technology 
makes its technology available to commercial partner that 
will exploit the technology. Technology transfer is very 
helpful to develop the dosage forms in different ways as it 
provides efficiency in the process, maintains the quality of 
the product, helps to achieve the standardized process 
which facilitates the cost effective production. The 
commercial technology transfer can be defined as the 
mutually agreed and goal oriented. The transfer can be said 
to be successful if the receiving unit and the transfer can 
effectively utilize the technology for the business gain. The 
success of any technology transfer depends upon the 
process understanding or the ability of predicting accurately 
the future performance of the process. The cost of the 
product development rises during the pilot scale-up and 
initial the production batch that is the critical path for the 
success is dependent on the completion of technology 
transfer to the production site at a cost that is affordable. 
 
Fig. 1: Flow of stages involves after receiving the 
technology from R&D to PDL till commercialization of 
that technology in a pharmaceutical industry 
 
1.1 Why technology transfer is required in 
Pharmaceutical Industry:[10-12] 
In the pharmaceutical industry technology transfer 
refers to the processes that are needed for successful 
progress from drug discovery to product development, to 
clinical trials to full scale commercialization or it is the 
process by which a developer of technology makes its 
technology available to commercial partner that will exploit 
technology. In pharmaceutical industry preparation of 
dosage form needs scale up at several stages, such as small 
scale laboratory development from 0.5-2 kg batch can be 
scaled up to 5-10 kg and then to 20-100 kg on a pilot scale. 
Production scale can typically range from 200 kg to greater 
than 1000 kg. Technology transfer involves manufacturing 
drug product with increasing batch sizes on larger 
equipment or using continuous processing on pilot scale 
equipment. Generally scale up involves the transfer of 
technology and the transfer of knowledge that has been 
accumulated during the small scale development of product 
and processes. It is important to realize that good 
communication is critical for formulation and process 
transfer to be successful. It is essential for a researcher or 
developer of technology to make available this technology 
to another person’s to exploit for the progress of 
development of technology and for exploitation of a 
technology in different fields of applications and to make is 
use with another organization that may have better 
manufacturing capability, marketing capability and 
commercial capability. In the pharmaceutical industry, 
technology transfer by collaborating with other departments 
and other organizations to commercialize a pharmaceutical 
product is a common process. 
 
1.2 Importance of technology transfer in 
pharmaceutical industry [13, 3]
 
 Demonstration of necessary information to technology 
transfer from R&D to actual manufacturing. 
 Demonstration of necessary information to technology 
transfer of existing product between various 
manufacturing sites. 
 For the smooth manufacturing of commercialized 
products 
 General impact of the technology transfer program. 
1.3 Reasons for technology transfer [9-12] 
There may be many reasons why a developer of 
the technology might consider making its technology 
available to another person to exploit, instead of exploiting 
the technology itself.  
Forming alliances with partners that can progress the 
development to take it to market 
The developer of the technology might have the 
resources to take the technology to particular state of 
development, such as up to animal studies and toxicology 
studies, but does not have the resources to take the 
technology through its regulatory phases and must 
collaborate with another organization to take it through 
these phases and into the market.  
Forming alliances with partners with manufacturing 
capability 
The developer of the technology may have taken 
the technology to a state of development so that it is near 
market ready but does not have the clean room 
manufacturing capability or resources to manufacture the 
product and must partner with another organization that 
does have the capability. The developer of technology may 
only have manufacturing equipment which is suitable for 
small scale operation, and must collaborate with another 
organization to do large scale manufacturing.  
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Forming alliances with partners with marketing and 
distribution capability 
The developer of the technology may have fully 
developed the technology and even have obtained 
regulatory approvals and product registrations for the 
product to be sold but it lacks the marketing and 
distribution channels to give it a marking capability and 
must collaborate with another organization that does have 
that capability.  
Lack of resources to launch product commercially:  
The original inventor of technology may only have 
the resources to conduct early-stage research such as animal 
studies and toxicology study, but doesn’t have the resources 
to take technology through its clinical and regulatory 
phases.  
No commercial capability 
The developer of the technology may be research 
institute of a University, which does not have the capability 
to exploit commercially at all, and need to collaborate with 
another organization that does have that capability. In the 
exploitation of pharmaceutical products, technology 
transfer by collaborating with this way to bring a 
pharmaceutical product to market is common feature of the 
industry. 
 
2. Methods technology transfer:[14] 
Technology Transfer can be done in various ways 
such as contract Research and Development, establishment 
of joint ventures, setting up plants, licensing patents, 
designs etc. Licensing is however the most common 
method of technology transfer that grants the right to 
1. Licensing in:  
In this strategy companies that are small and lack 
facilities to do basic research would wish to buy other’s 
research. Also large scale and research based companies 
also might like to license in technology to expand its 
product line. 
2. Licensing out:  
In this, small scale companies that only have 
patents as their assets and cash in scarce would like to 
license out, whereas large companies license out technology 
if it is of very little knowledge for them. 
2.1 Facets of technology transfer: [9] 
a) Govt. laboratories to private sector. 
b) Between private sectors of same country. 
c) From academics to private sectors. 
d) Between academy, private and govt. sectors 
a. Govt. labs to private sectors: 
This type of technology transfer is advantageous 
as the Govt. labs can get good financial support and funds 
from the govt. for their research work and the technology 
developed by them reaches the private sector. 
b. Between private sectors of same country: 
This type of technology transfer generally occurs 
due to lack of appropriate financial resources or inadequate 
knowledge of regulatory requirements, thus the private 
sector that develops the technology is paid by other sector 
that absorbs the technology. 
c. From academics to private sectors: 
Academic sectors that are actively involved in 
research and development the technology and make it 
available to private firms. By collaboration of private firms 
with the institutions, money can be saved. 
d. Between academy, private and govt. sectors: 
In this type of technology transfer govt. provides 
necessary funds to the academic institutions in developing 
technology that can be transferred to the industry.
 
2.3 List of institutes in India assisting in Technology 
Transfer: [15] 
1. Asia Pacific Centre for Transfer of Technology: C2, 
Qutab Institutional Area, New Delhi -110016. Phone no- 
011 30973700 
2. National Research & Development Corporation: 20-22, 
Zamroodhpur Community Center, Kailash colony, New 
Delhi-110048. Phone No-011 26489037 
3. Technology Bureau for Small Enterprises: Room no-123, 
Udyog Bhawan, Rafi marg, New Delhi-110011. Phone no- 
011 23061431 
4. Foundation for Innovation & technology transfer: Indian 
Institute of Technology Hauzkhas, New Delhi-110016. 
Phone no- +91 1126857762 
 
3. Organization of technology transfer: 
Since a team concept is always the best approach 
to accomplishing a successful technology transfer project. 
The core technology transfer team should be commissions 
immediately following the decision of executive 
management to pursue the drug candidate to 
commercialization. Typical technology transfer core team 
will likely be comprised individuals representive of 
different segments of the business. 
1) Project Manager: 
For overall responsibility coordination and 
progress communication to management. His or her role 
may be enhanced as necessary by additional staff & 
responsibility and authority delegated as appropriate. 
2) Regulatory Affairs: 
For coordination of the appropriate regulatory 
filings, advice on approval timing, content of the filing 
documentation and response to regulatory inquiries. 
3) Engineering: 
To coordinate associated capital projects and direct 
and control construction, equipment acquisition, installation 
and qualification. 
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4) Material management: 
To include those units responsible for pure 
chasing, strategic planning, resource allocation and supply 
chain activities. This member (or members) will analyse 
and recommend the most favorable manufacturing strategy 
in consideration of internal capability, business partnership 
and tax advantages for the corporation. 
5) Manufacturing operations: 
 To represent the originating site and receiving 
location production activities. These representatives should 
have sufficient authority to commit the necessary personal 
and plant resource to accomplish the project within the 
defined cost and time limitations. 
6) Research and Development: 
To support the technical issues and resolve 
problems. This groupprovides the process expertise and 
would be expected to train and direct the production trials 
atreceiving site. 
3.1 Function of technology transfer team:[16]  
1. Coordinate: Coordinating between technology users 
and developer between researcher and manufacturers is 
important element of technology transfer.  
2. Nurture: A main ingredient for moving technology 
from a research laboratory to new business enterprises 
successfully in an environment that is supportive for 
entrepreneurship. 
3. Link: Cataloging resources related to business 
enterprises and connecting would be entrepreneurship/ 
researcher and other technology developers to outside 
group & organization which can help in the process of 
starting new product, companies etc. such linkage 
provide referrals for individual business counseling 
sources of financing. 
 
4. Steps in technology transfer process: [17] 
Technology transfer is not a single way process. 
The development of new formulation goes through many 
stages. During development of a formulation, it is 
important to understand procedure of operations used, 
critical and noncritical parameters of each operation, 
production environment, equipment and excipient 
availability, which should be taken into account during the 
early phases of development of formulation, so that 
successful scale up can be carried out. Appropriate care 
during technology transfer is important to enhance drug 
quality as developed by research and development in final 
formulation as well as to assure quality for predetermined 
period of time.
 
 
Fig. 2: Flow chart for technology transfer 
TTD: Technology Transfer Dossier, MFC: Master Formula Card, PE: Pre Exhibit, EB: Exhibit Batch, BPR: Batch 
Packaging Record, BMR: Batch Manufacturing Record. 
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 Development of technology by research and 
development (Research phase) 
 Technology transfer from research and development 
to production (Development phase) 
 Optimization and Production (Production phase) 
1) Research phase (Development of technology by 
research and development):  
a. Quality Design: 
 For drug products the quality design corresponds to 
pharmaceuticals design to design properties and 
functions such as 
 Elimination of adverse reactions 
 Improvement of efficacy 
 Assurance of stability during distribution 
 Data based on various data such as chemical and 
physical properties, efficacy, safety and stability 
obtained from preclinical studies 
 For drug substance the quality design is to determine 
starting materials and their reaction paths and basic 
specification of the drug.  
2) Development Phase:  
a. Research for factory production:  
To manufacture drugs with qualities as designed, it 
is required to establish appropriate quality control method 
and manufacturing method, after detecting variability 
factors to secure stable quality in the scale up (validation) 
that is performed to realize factory production of drug 
designed on the basis of result from small scale 
experiments.  
b. Consistency between Quality and Specification:  
When product specification is established on the 
basis of the quality of the product determined in the above, 
it is required to verify that the specification adequately 
specifies the product quality. Relations between upper and 
lower limits of manufacturing formula (composition and 
manufacturing methods) and upper and lower of control 
limits of the product specification should be fully 
understood, and the consistency between the product 
quality and specifications should be maintained.  
In short, the consistency between quality and 
specification is to ensure in the products specification that 
the quality predetermined in the quality design is assured as 
the manufacture quality, and the product satisfies the 
quality of design.  
c. Assurance of consistency through development and 
manufacturing:  
For this purpose, the transferring party in charge of 
development should fully understand what kind of technical 
information is required by the transferred party in charge of 
manufacturing and should establish an appropriate 
evaluation method to determine whether a drug to be 
manufactured meets the quality of design. For stable 
production of consistent products, it is fundamental to fully 
refer to information of similar products of the past 
maintained by the manufacturer when research for factory 
production is implemented. 
d. Technology Transfer from R&D to Production:[9] 
R&D provides technology transfer dossier (TTD) 
document to process development laboratory, which 
contains all information of formulation and drug product 
as given below:  
 Master formula card (MFC): It includes product name 
along with its strength, generic name, MFC number, page 
number, effective date, shelf life and market.  
 Master packaging card: It gives information about 
packaging type, material used for packaging, stability 
profile of packaging and shelf life of packaging.  
 Master formula: It describes formulation order and 
manufacturing instructions. Formulation order and 
manufacturing instructions gives idea of process order, 
environment conditions required and manufacturing 
instructions for dosage form development.  
 Specifications and standard test procedure (STPs): It 
helps to know active ingredients and excipients profile, 
in- process parameters and specifications, product release 
specification and finished product details.  
3) Production Phase:  
a. Validation and Production:  
Production is implemented after various validation 
studies verify that it is able to stable product based on 
transferred manufacturing formula. While the 
manufacturing facility accepting technology is responsible 
for validation, the research and development department 
transferring technology should take responsibility for 
validation such as performance qualification, cleaning 
validation, and process validation unique to subject drugs.  
b. Scale up for production:  
Scale up involves the transfer of technology during 
small scale development of the product and processes. It is 
essential to consider the production environment and 
system during development of process. Operators should 
concentrate on keeping these things in mind that their 
segment of the production process running smoothly if 
technology transfer is implemented thoughtfully. Effective 
technology transfer helps to provide process efficiency and 
maintain product quality. 
c. Considerations of different parameters for scale-up:  
Before starting scale-up, we also considered 
different parameters that should be optimum for successful 
technology transfer. These were flexibility, cost, 
dependability, innovation and product quality. It was 
important to realize that good communication was critical 
for formulation and process transfer to be successful.  
d. Selection of method:  
The method for batch fabrication was selected on 
the basis of data given from research and development. 
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Granulation, blending, compression and coating were 
critical parameters for technology transfer. 
 
5. Technology Transfer Documentation: [12-18] 
Generally interpreted as document indicating 
contents of technology transfer for transferring and 
transferred parties. Each step from research and 
development to production should be documented, task 
assignments and responsibilities should be clarified and 
acceptance criteria for completion of technology transfer 
concerning individual technology to be transferred. It is 
duty of quality assurance department to check and approve 
the documentation for all processes of technology transfer. 
(a) Development Report: 
The research and development report is a file of 
technical development, and research and development 
department is in-charge of its documentation. This report is 
an important file to indicate rationale for the quality design 
of drug substances and its specifications and test methods. 
The development report is not prerequisite for the 
application for approval it can be used at the pre-approval 
an inspection as valid document for quality design of new 
drug. The development report contains –  
1) Data of pharmaceutical development of new drug 
substances and drug products at stages from early 
development phase to final application of approval.  
2) Information of raw materials and components.  
3) Design of manufacturing methods. 
4) Change in histories of important processes and control 
parameters. 
5) Specifications and test methods of drug substances.  
6) Validity of specification range of important tests such as 
contents impurities and dissolution.  
7) Verifications of results. 
(b) Technology Transfer Plan: 
The technology transfer plan is to describe items 
and contents of technology to be transferred and detailed 
procedures of individual transfer and transfer schedule, 
establish judgment criteria for the completion of the 
transfer. The transferring party should prepare the plan 
before the implementation of the transfer and reach an 
agreement on its contents with the transferred party. 
(c) Technology Transfer Report: 
Completion of technology transfer is to be made 
once data are taken accordingly to the technology plan and 
are evaluated to confirm that the predetermined judgment 
criteria are met. Both transferring and transferred parties 
should document the technology transfer report. 
Exhibit batches: After taking scale up batches of the 
product, manufacturing of exhibit batches takes place. In 
case of exhibit, batch sizes are increased along with 
equipments and their processes. This is done for filling 
purpose in regulatory agencies. The purpose behind to run 
three consecutive batches are to shows process consistency 
reproducibility and to demonstrate that the manufacturing 
process is under control throughout all the stages. 
5.1 Effective factors in technology transfer: [19] 
“Technology transfer can be considered successful 
if a receiving unit can routinely reproduce the transferred 
product, process or method against a predefined set of 
specifications as agreed with a sending unit and/or a 
development unit”. Main factors that affect the process of 
technology transfer in pharmaceutical industry are as 
follows: 
1) Investment in Research and Development. 
2) Establishing relationship between production and 
research. 
3) Training of individual in relation of technology. 
4) Information development in the field of technology 
transfer methods. 
5) Organizational, equipmental and informational 
infrastructures. 
6) Employment of international specialist in the field of 
technology and creation of appropriate relationship 
between recipient and sender technology. 
7) Awareness of fundamental and important factors 
required for technology transfer. 
8) Consideration of existing and old technologies. 
9) Degree of development and improvement of technology 
on the basis of internal resources. 
5.2 Unsuccessful technology transfer process may be 
due: 
1) Unsuccessful or incomplete process validation. 
2) High rates of batch rejections, excessive labour 
requirements, increased cost of product etc. 
3) Incomplete documentation. 
4) Product does not show specifications as intended. 
5) Delayed regulatory approval and/or product launch.  
 
6. Few cases of technology transfer: [20-25] 
The process of technology transfer is actively 
being pursued in India through Government laboratories, 
Academics Institutions and Commercial entities. 
1. The Bhabha Atomic Research Centre (BARC) has 
developed and transferred around 90 technologies in the 
areas such as environment and health, electronics, electrical 
and mechanical, chemical and metallurgy, radioisotope and 
applications. 
2. The National Chemical Laboratory (NCL) Pune has 
several linkages with Universities and pharmaceutical 
industries to ensure successful scale up and implementation 
of technology. 
3. Department of Biotech (DBT) has successfully 
transferred some techniques of forest trees through tissue 
culture. 
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4. Eli Lily has entered in technology transfer agreement 
with Shasun Chemicals and Drugs for the manufacturing of 
anti-Tuberculosis drug Cycloserine produced by Shasun to 
meet Eli Lily global demand.
 
Other pharmaceutical companies like Wockhardt 
Ltd, Cipla Ltd, Torrent Pharmaceutical Ltd, Dr. Reddy’s 
Laboratories Ltd, USV Ltd have already signed in-licensing 
agreements with foreign drug markers.
 
5. Central Drug Research Institute (CDRI): has 
developed technologies in the areas such as Malaria and 
other parasitic diseases, CNS-CVS related disorder, 
reproductive health, diabetes and energy metabolism, 
cancer biology and related areas, safety and clinical 
development. 
6. Tata Institute of Fundamental Research: has 
successfully transferred some techniques of mathematics, 
natural sciences, computer sciences, biological sciences. 
 
7. Conclusion 
Appropriate technology transfer is important to 
upgrade the quality of design to be the quality of product, 
and ensure stable and high quality of the product. A healthy 
communication between different countries and different 
organizations are the key to the success of technology 
transfer and development. So the knowledge and 
information should be transferred equally and continuously 
from transferring party to the transferred party, this will 
help in the product manufacturing process and thus the 
development of both the parties. Technology Transfer 
provides an opportunity to reduce cost on drug discovery 
and development thus major pharmaceutical companies 
look for technology transfer opportunity as it reduces risk, 
cost and rate of failure. The three primary considerations to 
be addressed during an effective technology transfer are the 
plan, the persons involved, and the process. Licensing is an 
important phenomenon of technology transfer that has 
gained momentum in pharmaceutical industry by which 
pharmaceutical companies can contribute to research and 
development. Technology transfer is a complex issue and 
should be deal with using holistic approach. 
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